Topic: CATCHING CANCER EARLY: Assessing the need for and effectively implementing a care delivery model for hereditary cancer
Aired: Tuesday, September 22nd from 12 – 12:45 p.m. ET
– Matthew Lederman, M.D., Reproductive Endocrinologist and Infertility Specialist at RMA of New York
– Elizabeth Etkin-Kramer, M.D., FACOG, Associate Professor in OBGYN at FIU Herbert Wertheim College of Medicine
– Jill Chisholm, APNG President and Founder of GeneScreen and Chief Medical Officer of Synergenomics
The accessibility of next-generation sequencing (NGS), new clinical guidelines on the role OBGYN care providers play in identifying and managing women with hereditary breast and ovarian cancer syndrome, and evolving practice business needs have led to an increasing importance and application of inherited cancer predisposition testing.
Join the conversation with Dr. Matthew Lederman, Dr. Elizabeth Etkin Kramer, and Jill Chisholm on the various considerations for, and the importance of, identifying those at risk for inherited cancer syndromes and how that necessitates updates to clinical management. This live panel discussion will cover assessing risk through patient-provider engagement, integrating programs to complement protocols, and delivering results into physicians’ workflows to improve patient outcomes.
Learn about the most up to date clinical guidelines here: ACOG Hereditary Cancer Syndromes and Risk Assessment